Principal Investigator, NHLBI R01 HL164777 at Columbia University Health Sciences
2023 to 2028 · Last known relationship
Matthew R. Baldwin is an Associate Professor of Medicine at Columbia University Irving Medical Center, a pulmonary and critical care physician and a clinical investigator with an MS in biostatistics from Columbia's Mailman School. He earned his MD at Columbia P&S, trained in internal medicine at Johns Hopkins Hospital and completed the Columbia Pulmonary and Critical Care fellowship (2008–2012), where his project was on critical care outcomes in the elderly. His research aims to improve critical illness survivorship across four lines: endophenotyping acute respiratory failure and COVID-19 survivors (frailty subtypes, GDF-15, inflammation), reverse-translational cellular therapeutics for ARDS, risk prediction and disparities, and palliative care interventions such as chaplain-led picture-guided spiritual care for ventilated patients; he currently leads NHLBI R01 HL164777 on determinants of recovery in ARDS survivors and previously held an NIA K23 and a Department of Defense award on COVID-19 lung injury sub-phenotypes. He sits on the editorial board of Annals of the American Thoracic Society, serves on the DSMB of the NHLBI NEXIS trial and reviews for VA, DoD and international funders.
Each topic is linked to its supporting source in Sources.
Training includes Principal Investigator, NHLBI R01 HL164777 at Columbia University Health Sciences, Co-leader, Geriatrics, Integrating Special Populations Research, Irving Institute for Clinical & Translational Research (UL1 TR001873) at Columbia University Irving Medical Center, Columbia University Irving Medical Center, and MD, plus 6 more records.
Explore education and training2023 to 2028
2016 to 2025
2008 to 2012
Airway-administered cellular therapeutics to resolve inflammation in ARDS (reverse translation)[10]
ARDS / Acute Respiratory Failure / Chronic critical illness[10]
Clinical risk prediction modeling and health disparities outcomes[10]
Critical illness survivorship: endophenotyping acute respiratory failure and COVID survivors to find mechanisms of physical impairment[10]
Lung Transplantation[10]
Measuring and treating frailty among elderly survivors of critical illness[10]
Palliative care interventions to improve ICU survivorship (e.g., chaplain-led communication-board spiritual care)[10]